Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.

Gabapentinoids -- pregabalin and gabapentin -- were tied to increased hip fracture risk in older adults. Gabapentinoids -- ...

Gabapentin is a prescription medication that was approved by the U.S. Food and Drug Administration in 1993 as a treatment for epilepsy ... a specific type of nerve pain called post-herpetic neuralgia ...

The findings represent an important step toward developing new, potentially less toxic treatments. The compound, known as cordycepin, is produced by a parasitic fungus called Cordyceps militaris ...

We worked with dermatologists to find the best acne treatments. Our top picks include prescription tretinoin cream and oral antibiotics as well as OTC salicylic acid toners and niacinamide serums.

There are a number of treatment options for ED. Initially, a provider may advise the patient to take steps to improve their lifestyle habits, such as increasing their level of physical activity ...

Crisugabalin at 40 mg/d or 80 m/d for postherpetic neuralgia treatment led to statistically significant improvement in average daily pain scores. Crisugabalin as a treatment for postherpetic ...

With the best flea and tick treatments for cats, you can safely and effectively prevent and eliminate not only fleas and ticks but also parasites like worms and lice. To choose the top cat flea ...

for trigeminal neuralgia (TN), including patients with multiple sclerosis, to bring new insight about the role of microvascular compression in the pathogenesis of the disorder and the role of MVD in ...

OHSU patients benefit from research that has transformed the understanding and treatment of trigeminal neuralgia. Our research has made OHSU an international leader in diagnosing and treating facial ...

The convergent inputs to the central projection of the trigeminovascular system, the trigeminal nucleus caudalis ... and the preventive treatments anti-epileptics, including topiramate, have ...